Author information:
(1)Cell Proliferation Group, MRC Clinical Sciences Centre, Imperial College 
London, Hammersmith Campus, London W12 0NN, UK.
(2)Epigenetics Section, MRC Clinical Sciences Centre, Imperial College London, 
Hammersmith Campus, London W12 0NN, UK.
(3)Metabolic Signalling Group, MRC Clinical Sciences Centre, Imperial College 
London, Hammersmith Campus, London W12 0NN, UK.
(4)Cancer Sciences Unit, Cancer Research UK Centre, Somers Building, University 
of Southampton, Southampton SO16 6YD, UK.
(5)Division of Molecular Oncology of Solid Tumors, Department of Internal 
Medicine I, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
(6)Proteomics Facility, MRC Clinical Sciences Centre, Imperial College London, 
Hammersmith Campus, London W12 0NN, UK.
(7)Developmental Biology and Cancer Programme, Birth Defects Research Centre, 
UCL Institute of Child Health, London WC1N 1EH, UK.
(8)Institute for Virology, Technische Universität München/Helmholtz Zentrum 
München, 81675 Munich, Germany.
(9)Division of Chronic Inflammation and Cancer, German Cancer Research (DKFZ), 
69121 Heidelberg, Germany.
(10)Department of Pathology and Geriatrics Center, University of Michigan, Ann 
Arbor, Michigan 48109-2200, USA.